The number of platform location crosses was significantly increased in the AAV-ACAA1 WT group compared to the AAV-Vector group in APP/PS1ΔE9 mice in the 72-h probe trial, indicating potentially beneficial effect of delay in the development of AD in this murine model (Fig. 3d). Here, APP is linked to Alzheimer disease.